CCL2 and myelodysplastic syndrome: Along with TG, the expression of other NF-κB targets, such as IL6 and CCL2, was concurrently increased in the colons of MDs with the risk allele T/T, strengthening the conclusion that TG is a potential therapeutic target for ICRP.